Skip to main content
Caplight Logo









1910 Genetics

1910 Genetics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.1910.ai/

Last Round

Series A

Extension

Oct 31, 2024

Total Funding Raised

$44.65M

Company Overview

1910 Genetics is a biotechnology company that provides a drug discovery platform utilizing multimodal AI and laboratory automation to enhance productivity and reduce failure rates in small and large molecule drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Infrastructure

Keywords

drug discoveryAI drug discoverybiotech AIin silico drug discoverycomputational biologysmall molecule designprotein therapeuticshigh-performance computingHPCblood-brain barrier predictionwet-lab automationdrug discovery platformplatform-as-a-servicePaaSpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1910 Genetics Comparables

Compare 1910 Genetics with similar companies based on industry and business-model similarity.

1910 Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genesis Molecular AI
85%
Terray Therapeutics
82%
Insilico Medicine
78%

1910 Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 31, 2024
GrantSep 30, 2021
Series AMar 23, 2021

1910 Genetics Investors

Notable investors and investment history

1910 Genetics investors
InvestorRounds
Scientia VenturesSeed, Series A
EmlesSeed, Series A
NIH RADxGrant
FoundersX VenturesSeed
Playground GlobalSeries A
M12 - Microsoft's Venture FundSeries A
Accenture VenturesSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 30, 2021

    $546K grant received from NIH RADx

1910 Genetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

1910 Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 1910 Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range50
Year Founded2018
Last FundingOct 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?